Home/Filings/4/0001376339-23-000031
4//SEC Filing

Stein Robert Benjamin 4

Accession 0001376339-23-000031

CIK 0001376339other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 6:26 PM ET

Size

7.0 KB

Accession

0001376339-23-000031

Insider Transaction Report

Form 4
Period: 2023-05-15
Stein Robert Benjamin
EVP, Research and Development
Transactions
  • Sale

    Common Stock

    2023-05-16$5.95/sh10,365$61,627317,803 total
  • Sale

    Common Stock

    2023-05-15$6.15/sh3,607$22,170328,168 total
Footnotes (2)
  • [F1]The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $6.120 to $6.190, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.
  • [F2]The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $5.870 to $6.025, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.

Issuer

MIMEDX GROUP, INC.

CIK 0001376339

Entity typeother

Related Parties

1
  • filerCIK 0001597158

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 6:26 PM ET
Size
7.0 KB